
Niacinamide: Supports barrier function, uneven tone and oiliness. Polyhydroxy Acids: Offers exfoliation through ingredients such as gluconolactone and lactobionic acid.


Choose for barrier support, uneven tone and oiliness; often the gentler starting point.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
Can you use both?
A gentle pairing: PHAs exfoliate lightly and niacinamide calms.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

















Supports the skin barrier: Helps skin make lipids that reduce water loss. Reduces pigment transfer: Less pigment reaches neighboring skin cells.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens surface cells: PHAs promote shedding in the outer skin. Helps bind water: Hydroxyl groups contribute to water binding.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Clinical studies commonly use 2–5% niacinamide for particular concerns. Higher marketed strengths are not a proven upgrade for everyone.
2%
4–5%
10%
Studied for facial oiliness
Controlled studies tested a finished formula for measures of facial oiliness; results do not mean every oily skin needs niacinamide.
Studied for tone and skin aging
Different trials studied pigmentation, melasma or fine lines. The concern and finished formula matter.
Higher marketed concentration
Available in skincare, but not established as universally more effective than the lower studied strengths.
Choosing a strength: A comfortable 2–5% product is a reasonable place to look when choosing for the studied concerns; evaluate the complete formula.
Higher strengths: Higher percentages may sting or irritate some skin. Do not keep increasing the concentration when the product causes discomfort.
Formula matters: Niacinamide is also included in moisturizers without a stated percentage. That does not mean the moisturizer cannot support skin comfort.
PHA is a family name, not one ingredient or one standard strength. A clinical acne trial used 14% gluconolactone; that result cannot be transferred directly to lactobionic acid or mixed-PHA products.
14%
Studied gluconolactone lotion
An older controlled acne trial tested this specific formula. It does not establish the best percentage for all PHA skincare.
Choosing a strength: Check which PHA is listed, whether the product stays on or washes off, and whether it also contains other exfoliating acids.
Higher strengths: A PHA product can still irritate, particularly when combined with other acids. A high total-acid percentage is not a validated benefit rating.
Formula matters: The individual acid, acidity and base formula matter. A blended-acid percentage does not reveal the amount of each PHA.
Approximate windows, not promises.
First few weeksAssess comfort. Moisturizer benefits may appear before changes in tone or lines.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksOiliness or uneven pigmentation may begin to improve.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksReassess tone and fine lines; expect modest changes.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsContinue if it helps and remains comfortable.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term benefit is less well defined than short-term results.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Stinging, redness, dryness or a rash can occur. Fragrance, preservatives and other ingredients may also contribute to a reaction.
Can still sting or cause a rash; sensitive skin does not guarantee tolerance.
Stop for persistent burning, swelling or an itchy rash. Seek urgent help for trouble breathing or rapidly worsening facial swelling.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a gentle formula and test a small area. Barrier-support claims do not mean every product suits rosacea or eczema.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
This topical ingredient is not a retinoid. Review the complete product with your clinician; do not assume every combination formula is suitable.
Niacinamide supports skincare; it does not replace diagnosis or established treatment of persistent acne, melasma or an inflamed rash.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Low-strength leave-on acids are generally considered acceptable; ask the clinician managing your pregnancy.
On the skin. A water-soluble vitamin used in serums and moisturizers.
Entering skin. Human studies show delivery into the outer skin; uptake depends on the formula.
Conversion. Cells use niacinamide to help make NAD+, which supports energy and repair.
Skin response. Supports production of barrier lipids, including ceramides, and helps reduce water loss.
Additional effects. Reduces pigment transfer between skin cells in laboratory models.
On the skin. The finished product delivers polyhydroxy acids in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. PHA ingredients promote surface exfoliation and may also bind water; individual acids and formulas differ.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
There is clinical evidence, including a small 12-week controlled trial of a 5% moisturizer. Expect modest improvement; it does not erase deep wrinkles.
Not necessarily. Many clinical studies used 2–5%, and a higher concentration is not proven to work better for every concern.
Small trials suggest benefit, but the evidence is limited. Persistent, painful or scarring acne needs an established acne treatment plan.
That has not been established. Less oil or a smoother appearance can make pores look less obvious without permanently changing their structure.
The concentration, other ingredients or your skin barrier may be responsible. Reduce use or stop if irritation persists; you do not need to push through it.
Choose for mild exfoliation when stronger acids are uncomfortable; tolerance still varies.
A 150-person trial tested 14% gluconolactone for acne. Evidence from that molecule or a mixed-acid serum does not establish identical effects for all PHAs.
Sources